Zobrazeno 1 - 10
of 131
pro vyhledávání: '"HJ Weinstein"'
Publikováno v:
Blood. 63:800-802
Cytogenetic studies were performed in 18 consecutive children with acute nonlymphocytic leukemia (ANLL) between 1981 and 1983. Three children with acute myelomonocytic leukemia (AMMoL; M4, FAB classification) had the following unique bone marrow morp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44e48c96768cc1baf59c66e6446fc732
https://doi.org/10.1182/blood.v63.4.800.800
https://doi.org/10.1182/blood.v63.4.800.800
Publikováno v:
Blood. 62(3)
A series of monoclonal antibodies reactive with normal myeloid cells at different stages of differentiation (anti-MY4, -MY7, -MY8, -Mo1, -Ia) were used to characterize the leukemic cells of 70 patients with acute myeloblastic leukemia (AML). Sixty-tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092834877bf92e1b0b644c6c08204e22
https://pubmed.ncbi.nlm.nih.gov/6309279
https://pubmed.ncbi.nlm.nih.gov/6309279
Publikováno v:
Blood. 62(2)
We designed a protocol (VAPA) that featured 14 mo of intensive postremission induction chemotherapy in an effort to improve remission durations for patients with acute myelogenous leukemia (AML). One hundred and seven patients under 50 yr of age were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c9891a4ee53cff3aa8fc36b3eaee961
https://pubmed.ncbi.nlm.nih.gov/6575837
https://pubmed.ncbi.nlm.nih.gov/6575837
Publikováno v:
Blood. 64(2)
Twenty-nine patients with biopsy-proven malignant lymphoma of large- cell “histiocytic” type were treated with the APO protocol (vincristine, adriamycin, and prednisone). Treatment consisted of two years of therapy with a modified adriamycin-cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::627fd685e40f4cd1c0f10d19ed8fc84a
https://pubmed.ncbi.nlm.nih.gov/6378276
https://pubmed.ncbi.nlm.nih.gov/6378276
Publikováno v:
Blood. 59(6)
The pharmacokinetics of continuous subcutaneous cytosine arabinoside (ara-C) infusions were compared with continuous intravenous infusions. Steady-state serum ara-C levels and myelosuppression were similar with both routes of administration. CSF/seru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b0087a3950d424d53408af58abdd7d8
https://pubmed.ncbi.nlm.nih.gov/7082832
https://pubmed.ncbi.nlm.nih.gov/7082832
Publikováno v:
Blood. 73(2)
Therapeutic options for children with de novo or secondary myelodysplastic syndromes (MDSs) are limited. We report the outcome of eight pediatric patients (median age 12 years, range 3 to 19 years) with myelodysplasia who underwent allogeneic bone ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1d588082b26c645fe90e7222599d50
https://pubmed.ncbi.nlm.nih.gov/2644982
https://pubmed.ncbi.nlm.nih.gov/2644982
Publikováno v:
Blood. 72(2)
Renal disease has not been considered a major late complication of bone marrow transplantation. Of 31 evaluable pediatric patients undergoing allogeneic or autologous bone marrow transplantation for neuroblastoma or acute lymphoblastic leukemia, 14 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45d79c6cb9739d9a82687152404d643
https://pubmed.ncbi.nlm.nih.gov/3042040
https://pubmed.ncbi.nlm.nih.gov/3042040
Autor:
Feraco AM; Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Zhou Y; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN., Zheng Y; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN., Marks LJ; Stanford Children's Health, Stanford University, Stanford, CA., Friedmann A; Pediatric Hematology/Oncology, Massachusetts General Hospital for Children, Boston, MA., Weinstein HJ; Pediatric Hematology/Oncology, Massachusetts General Hospital for Children, Boston, MA., Link MP; Stanford Children's Health, Stanford University, Stanford, CA., Flerlage JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
Publikováno v:
Blood advances [Blood Adv] 2023 Nov 14; Vol. 7 (21), pp. 6665-6667.
Autor:
Frazer JK; Paediatric Hematology-Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Li KJ; Paediatric Hematology-Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Galardy PJ; Paediatric Hematology-Oncology, Mayo Clinic, Rochester, MN, USA., Perkins SL; Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA., Auperin A; Biostatistics and Epidemiology Unit, Gustave Roussy, Villejuif, France., Anderson JR; Frontier Science and Technology Research Foundation, Madison, WI, USA., Pinkerton R; University of Queensland, Brisbane, Queensland, Australia., Buxton A; Children's Oncology Group, Monrovia, CA, USA., Gross TG; Center for Global Health, National Cancer Institute, National Institute of Health, Rockville, MD, USA., Michon J; Paediatric Oncology Adolescent and Young Adult Department, Institut Curie, Paris, France., Leverger G; Paediatric Haematology and Oncology Unit, AP-HP, Armand Trousseau Hospital, UPMC Univ Paris 06, Paris, France., Weinstein HJ; Paediatric Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Harrison L; Paediatrics, New York Medical College, Valhalla, NY, USA., Shiramizu B; Paediatric Hematology-Oncology, University of Hawaii, Honolulu, HI, USA., Barth MJ; Paediatrics, Roswell Park Cancer Institute, Buffalo, NY, USA., Goldman SC; Paediatric Hematology-Oncology, Medical City Children's Hospital, Dallas, TX, USA., Patte C; Department of Cancerology for Children and Adolescents, Gustave Roussy, Villejuif, France., Cairo MS; Paediatrics, New York Medical College, Valhalla, NY, USA.; Medicine, Pathology, Microbiology and Immunology, and Cell Biology and Anatomy, New York Medical College, Valhalla, NY, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (2), pp. 374-377. Date of Electronic Publication: 2018 Aug 16.
Autor:
Lu BY; Division of Pediatric Hematology & Oncology, Massachusetts General Hospital for Children, Harvard Medical School, Boston, Massachusetts., Kojima L; Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Huang MS; Division of Pediatric Hematology & Oncology, Massachusetts General Hospital for Children, Harvard Medical School, Boston, Massachusetts., Friedmann AM; Division of Pediatric Hematology & Oncology, Massachusetts General Hospital for Children, Harvard Medical School, Boston, Massachusetts., Ferry JA; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Weinstein HJ; Division of Pediatric Hematology & Oncology, Massachusetts General Hospital for Children, Harvard Medical School, Boston, Massachusetts. hweinstein@mgh.harvard.edu.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2016 Nov; Vol. 63 (11), pp. 2042-5. Date of Electronic Publication: 2016 Jul 08.